Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).
Berra CC, Rossi MC, Mirani M, Ceccarelli Ceccarelli D, Romano C, Sassi L, Peretti E, Favacchio G, Pastore I, Folini L, Graziano G, Lunati ME, Solerte SB, Fiorina P.
Berra CC, et al. Among authors: folini l.
Front Endocrinol (Lausanne). 2023 Jan 18;13:1099451. doi: 10.3389/fendo.2022.1099451. eCollection 2022.
Front Endocrinol (Lausanne). 2023.
PMID: 36743930
Free PMC article.